Coronavirus disease (COVID-19) is an infectious disease which is caused by the SARS-CoV-2 virus. While the pandemic has just subsided, new COVID-19 variants keep hitting the people from around the world. According to experts, there is still much work to be done as new COVID-19 mutations bring forward concerns. As per the reports, the new omicron subvariant BA.2.75 is worrying the entire healthcare system.
Dr. Raj Rajnarayanan, assistant dean of research and associate professor at the New York Institute of Technology, told Fortune that it was the strain previously which was worrying experts, it is no longer a threat. However, BA.2.75.2, hasn’t been eliminated as a threat still.
According to the report, Dr. Anthony Fauci said that the emerging mutation was “suspicious” and could become a variant of concern in the coming fall. The evolution of tis variant is similar to BA.5, which is the dominant strain behind 83% of reported infections in the U.S., as per the data of Centers for Disease Control and Prevention.
BA.2.75.2 is now expanding its reach the Indian vicinity and accounts for about 0.5% of cases worldwide. The World Health Organization hasn’t separated this mutation from BA.2.75. However, it is singled out under “Omicron subvariant under monitoring.”
A preprint study, published in mid-September, reveals that the mutation exhibited a tendency to extensively escape neutralizing antibody treatments authorised by the Food and Drug Administration.
Symptoms of top Omicron variants
The most common omicron-related symptoms are:
- Loss of taste and smell
- Head and body ache
- Runny nose